Search

everythinglearnresearchcommunity

for

Search:↓

CD101 is highly effective in treating dermatophytosis in guinea pigs.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Santolina chamaecyparissus oil effectively fights fungal infections.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Some psychiatric medications can cause hair loss, but it usually grows back after adjusting the medication.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Cuscuta reflexa extracts helped regrow hair in rats with drug-induced hair loss.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Iron and zinc levels in hair are not linked to hair loss from chemotherapy.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.